| Credit Corp Group Limited (CCP) ORDINARY FULLY PAID |
Financials |
$909 |
Appendix 4E
|
4 Aug 2026 8:24AM |
$13.750 |
$13.350 |
fallen by
2.91%
|
|
CCP - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 7.4% to $585,952,000.
- Profit from ordinary activities after tax rose by 12.1% to $105,510,000.
- Interim dividend of 32.0 cents and final dividend of 45.5 cents per share, fully franked.
- Net tangible assets per ordinary share increased from $12.86 to $13.18.
- No control changes or investments in associates during the year.
- Financial statements have an unqualified audit opinion.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Audeara Limited (AUA) ORDINARY FULLY PAID |
Consumer Discretionary |
$6 |
Chip-level AI Licensing Partnership Commercial Production
|
4 Aug 2026 8:24AM |
$0.031 |
$0.033 |
risen by
6.45%
|
|
AUA - Price-sensitive ASX Announcement
Full Release
Key Points
- Audeara enters commercial production with Optek for chip-level AI licensing.
- First purchase orders valued at approximately A$31,000.
- Milestone marks transition from development to commercial deployment.
- Audeara's AI audio technology deployed on third-party semiconductor platforms.
- Establishes foundation for applications in consumer audio, hearables, and hearing-health.
- Fee-per-chip licensing model employed for revenue generation.
- Partnership validates Audeara's strategy of licensing AI audio technologies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ion Video Ltd (IOV) ORDINARY FULLY PAID |
Information Technology |
$59 |
Operating runway extended
|
4 Aug 2026 8:24AM |
$0.440 |
$0.440 |
fallen by
0%
|
|
IOV - Price-sensitive ASX Announcement
Full Release
Key Points
- $612,498 raised through the exercise of options issued in 2023 expiring in June/July 2026.
- Operating runway extended by six months to December 2027.
- Commercial activity progressing with meetings underway in the US.
- ION's board and management contributed $170,367, aligning interests with shareholders.
- With funds and cost control, operations are funded through December 2027.
- ION's capital structure now includes approximately 133.6 million shares and 21.5 million options.
- ION board and management hold about 35% of shares on a fully diluted basis.
- No commercial terms yet agreed in ongoing discussions in the US and with Australian Government.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| American Uranium Limited (AMU) ORDINARY FULLY PAID |
Materials |
$10 |
Lo Herma Resource Reaches 9.96Mlbs as Indicated Grows 72%
|
4 Aug 2026 8:24AM |
$0.068 |
$0.076 |
risen by
11.76%
|
|
AMU - Price-sensitive ASX Announcement
Full Release
Key Points
- Updated Mineral Resource Estimate at Lo Herma Project
- Total mineralisation of 7.16 million tonnes at 630 ppm U3O8
- Contained metal of 9.96 million pounds U3O8
- 4.79 million pounds classified as Indicated
- 5.17 million pounds classified as Inferred
- Significant increase from previous 8.57 million pounds
- Exploration Target Range increased to 5.88 to 7.90 million tonnes
- Scoping Study targeted for early Q4 2026
- Focus on In-Situ Recovery mining method
- Enhanced resource base supports future development studies
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Australian United Investment Company Limited (AUI) ORDINARY FULLY PAID |
Financials |
$2,606 |
Weekly NTA - 31 July 2026
|
4 Aug 2026 8:24AM |
$11.360 |
$11.970 |
risen by
5.37%
|
|
| Reef Casino Trust (RCT) ORDINARY UNITS FULLY PAID |
Consumer Discretionary |
$185 |
Change in substantial holding
|
4 Aug 2026 8:24AM |
$3.850 |
$3.770 |
fallen by
2.08%
|
|
| AuKing Mining Limited (AKN) ORDINARY FULLY PAID |
Materials |
$40 |
AuKing to Acquire High Grade Heavy Rare Earths Project
|
4 Aug 2026 8:24AM |
$0.021 |
$0.017 |
fallen by
19.05%
|
|
AKN - Price-sensitive ASX Announcement
Full Release
Key Points
- AuKing to acquire Machinga Heavy Rare Earths Project in Malawi.
- The project covers 200.4 square kilometers across two exploration licenses.
- Machinga hosts high-grade heavy rare earth enrichment.
- The acquisition involves staged payments and share issuance.
- AuKing aims to commence exploration activities immediately.
- The project is strategically located in a recognized rare earth mineral province.
- Historical results indicate significant rare earth potential.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Asian Investments Limited (RG8) ORDINARY FULLY PAID |
Financials |
$391 |
Update - Notification of buy-back - RG8
|
4 Aug 2026 8:23AM |
$2.570 |
$2.780 |
risen by
8.17%
|
|
| Vitrafy Life Sciences Limited (VFY) ORDINARY FULLY PAID |
Health Care |
$256 |
FY26 Corporate Governance Statement
|
4 Aug 2026 8:23AM |
$3.700 |
$4.100 |
risen by
10.81%
|
|
| Regal Partners Global Investments Limited (RG1) ORDINARY FULLY PAID |
Financials |
$627 |
Update - Notification of buy-back - RG1
|
4 Aug 2026 8:23AM |
$2.510 |
$2.690 |
risen by
7.17%
|
|
| Embark Early Education Limited (EVO) ORDINARY FULLY PAID |
Consumer Discretionary |
$83 |
Proposed issue of securities - EVO
|
4 Aug 2026 8:23AM |
$0.425 |
$0.408 |
fallen by
4.12%
|
|
| Vitrafy Life Sciences Limited (VFY) ORDINARY FULLY PAID |
Health Care |
$256 |
FY26 Appendix 4G
|
4 Aug 2026 8:23AM |
$3.700 |
$4.100 |
risen by
10.81%
|
|
| Vitrafy Life Sciences Limited (VFY) ORDINARY FULLY PAID |
Health Care |
$256 |
FY26 Full Year Results Presentation
|
4 Aug 2026 8:23AM |
$3.700 |
$4.100 |
risen by
10.81%
|
|
VFY - Price-sensitive ASX Announcement
Full Release
Key Points
- Executed key milestones across product, market development, and operations.
- Established U.S. market foundation and strategic partnerships.
- Achieved 94.4% post-thaw platelet recovery in USAISR Phase II study.
- Expanded blood sector commercial traction through key agreements.
- Advanced CGT market engagement, anticipating first revenue in FY27.
- Strengthened financial position with $41.2 million in cash and term deposits.
- Prepared to capitalize Guardion devices to balance sheet in FY27.
- Focus on scaling U.S. operations and expanding market reach.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Block, Inc. (XYZ) CDI 1:1 FOREIGN EXEMPT NYSE |
Financials |
$4,364 |
Statement of Changes in Beneficial Ownership
|
4 Aug 2026 8:23AM |
$116.500 |
$115.020 |
fallen by
1.27%
|
|
| Select Harvests Limited (SHV) ORDINARY FULLY PAID |
Consumer Staple |
$633 |
Update - Notification of buy-back - SHV
|
4 Aug 2026 8:23AM |
$4.190 |
$4.480 |
risen by
6.92%
|
|
| Vitrafy Life Sciences Limited (VFY) ORDINARY FULLY PAID |
Health Care |
$256 |
FY26 Appendix 4E and Annual Report
|
4 Aug 2026 8:22AM |
$3.700 |
$4.100 |
risen by
10.81%
|
|
VFY - Price-sensitive ASX Announcement
Full Release
Key Points
- Operating loss of $16.78 million for FY26.
- Sales revenue increased to $168,726.
- Received $3.45 million in government grants.
- Total comprehensive loss after tax of $16.17 million.
- Completion of a $30 million share placement.
- Cash position improved to $26.1 million.
- Employee benefit expenses were $7.58 million.
- Internal reporting reclassified for better management alignment.
- Key changes in executive team and compensation adjustments.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Reckon Limited (RKN) ORDINARY FULLY PAID |
Information Technology |
$49 |
HY26 Results Investor Presentation
|
4 Aug 2026 8:22AM |
$0.440 |
$0.430 |
fallen by
2.27%
|
|
RKN - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue of $32 million for HY26.
- EBITDA of $14 million and NPAT of $5 million.
- AI and innovation led to 30% efficiency gains.
- Reckon One billing grew by 23%.
- Investments in cloud products and AI solutions.
- Net debt reduced to $1.5 million.
- Declared dividend of 2.5 cents per share.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Embark Early Education Limited (EVO) ORDINARY FULLY PAID |
Consumer Discretionary |
$83 |
EVO Placement 4 August 26
|
4 Aug 2026 8:22AM |
$0.425 |
$0.408 |
fallen by
4.12%
|
|
EVO - Price-sensitive ASX Announcement
Full Release
Key Points
- Embark Early Education Limited (ASX:EVO) announced a $4.0 million placement.
- The placement includes issuing 10 million new shares at $0.40 each.
- Total issued share capital will increase to 213,661,284 shares.
- The placement funds will be used for asset acquisitions and transaction costs.
- Settlement and allotment dates are 7 and 10 August 2026, respectively.
- Canaccord Genuity (Australia) Limited is the lead manager.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Karoon Energy Ltd (KAR) ORDINARY FULLY PAID |
Energy |
$1,253 |
Update - Notification of buy-back - KAR
|
4 Aug 2026 8:22AM |
$1.735 |
$1.795 |
risen by
3.46%
|
|
| Amplia Therapeutics Limited (ATX) ORDINARY FULLY PAID |
Health Care |
$77 |
Amplia signs Collaboration and Supply Agreement with Lilly
|
4 Aug 2026 8:22AM |
$0.135 |
$0.150 |
risen by
11.11%
|
|
ATX - Price-sensitive ASX Announcement
Full Release
Key Points
- Amplia and Lilly sign a collaboration and supply agreement.
- The trial evaluates narmafotinib and olomorasib in NSCLC.
- Study extends narmafotinib's use beyond pancreatic and ovarian cancers.
- The trial will be conducted in Australia and the USA.
- FAK is identified as a mediator of resistance to KRAS inhibition.
- The collaboration is a strategic step for Amplia’s oncology expansion.
- Lilly provides in-kind supply of olomorasib for the study.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Reckon Limited (RKN) ORDINARY FULLY PAID |
Information Technology |
$49 |
2026 Half Year Results Summary
|
4 Aug 2026 8:22AM |
$0.440 |
$0.430 |
fallen by
2.27%
|
|
RKN - Price-sensitive ASX Announcement
Full Release
Key Points
- 23% revenue increase for Reckon One.
- 97% growth in Billing Workflows subscription revenue.
- Stable group EBITDA at $14 million.
- Net Profit After Tax (NPAT) increased by 6% to $5 million.
- Cloud-based subscription revenue grew by 2%.
- Net debt reduced to $1.5 million.
- Fully franked dividend of 2.5 cents per share declared.
- Continued transition and migration to cloud-based products.
- Investment in AI and strategic partnerships for growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Reckon Limited (RKN) ORDINARY FULLY PAID |
Information Technology |
$49 |
Dividend/Distribution - RKN
|
4 Aug 2026 8:22AM |
$0.440 |
$0.430 |
fallen by
2.27%
|
|
| Nordic Resources Limited (NNL) ORDINARY FULLY PAID |
Materials |
$79 |
Drill Re-starts at Finland Gold Projects - Two Rigs Planned
|
4 Aug 2026 8:22AM |
$0.180 |
$0.210 |
risen by
16.67%
|
|
| Reckon Limited (RKN) ORDINARY FULLY PAID |
Information Technology |
$49 |
Appendix 4D and Half Year Accounts
|
4 Aug 2026 8:21AM |
$0.440 |
$0.430 |
fallen by
2.27%
|
|
RKN - Price-sensitive ASX Announcement
Full Release
Key Points
- Half Year Ended – 30 June 2026
- Financial performance complies with Corporations Act 2001
- BDO Audit Pty Ltd conducted independent review
- No contraventions of auditor independence requirements
- Directors responsible for financial report preparation
- Condensed consolidated statement of financial position
- Compliance with AASB 134 Interim Financial Reporting
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| News Corporation (NWS) CLASS B VOTING COMMON STOCK-CDI 1:1 |
Communication Services |
$1,777 |
Appendix 3C
|
4 Aug 2026 8:21AM |
$44.920 |
$47.240 |
risen by
5.16%
|
|